Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
2001 1
2004 2
2006 2
2007 2
2008 4
2009 5
2010 7
2011 4
2012 5
2013 1
2014 4
2015 11
2016 7
2017 10
2018 5
2019 7
2020 7
2021 11
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of emapalumab in macrophage activation syndrome.
De Benedetti F, Grom AA, Brogan PA, Bracaglia C, Pardeo M, Marucci G, Eleftheriou D, Papadopoulou C, Schulert GS, Quartier P, Antón J, Laveille C, Frederiksen R, Asnaghi V, Ballabio M, Jacqmin P, de Min C. De Benedetti F, et al. Ann Rheum Dis. 2023 Jun;82(6):857-865. doi: 10.1136/ard-2022-223739. Epub 2023 Mar 31. Ann Rheum Dis. 2023. PMID: 37001971 Free PMC article.
The investigated dosing regimen, based on an initial loading dose followed by maintenance doses, was appropriate, as shown by rapid neutralisation of IFNgamma activity, demonstrated by a prompt decrease in serum C-X-C motif chemokine ligand 9 (CXCL9) levels. By week 8, MAS …
The investigated dosing regimen, based on an initial loading dose followed by maintenance doses, was appropriate, as shown by rapid neutrali …
Statins in the treatment of acute ischemic stroke.
Montecucco F, Quercioli A, Mirabelli-Badenier M, Viviani GL, Mach F. Montecucco F, et al. Curr Pharm Biotechnol. 2012 Jan;13(1):68-76. doi: 10.2174/138920112798868737. Curr Pharm Biotechnol. 2012. PMID: 21470160 Review.
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (also known as statins) are drugs active in the blockade of cholesterol synthesis and thus lowering cholesterol serum levels. Since their discovery, experimental evidence showed that statins strongly redu …
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (also known as statins) are drugs active in the blockade of cholesterol …
Update on statin-mediated anti-inflammatory activities in atherosclerosis.
Montecucco F, Mach F. Montecucco F, et al. Semin Immunopathol. 2009 Jun;31(1):127-42. doi: 10.1007/s00281-009-0150-y. Epub 2009 May 5. Semin Immunopathol. 2009. PMID: 19415282 Review.
Statins have been introduced in the 1980s as 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to block cholesterol synthesis and lower cholesterol serum levels. In the last three decades, statins have been shown to possess several anti-inflammatory and antioxidan …
Statins have been introduced in the 1980s as 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to block cholesterol synthesis and l …
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Colafrancesco S, Alessandri C, Conti F, Priori R. Colafrancesco S, et al. Autoimmun Rev. 2020 Jul;19(7):102573. doi: 10.1016/j.autrev.2020.102573. Epub 2020 May 5. Autoimmun Rev. 2020. PMID: 32387470 Free PMC article. Review.
COVID-19 systemic inflammatory reaction and "hyperferritinemic syndromes" are all characterized by high serum ferritin and a life-threatening hyper-inflammation sustained by a cytokines storm which eventually leads to multi-organ failure. ...
COVID-19 systemic inflammatory reaction and "hyperferritinemic syndromes" are all characterized by high serum ferritin and a life-thr …
Proteomics and metabolomics characterizing the pathophysiology of adaptive reactions to the metabolic challenges during the transition from late pregnancy to early lactation in dairy cows.
Ceciliani F, Lecchi C, Urh C, Sauerwein H. Ceciliani F, et al. J Proteomics. 2018 Apr 30;178:92-106. doi: 10.1016/j.jprot.2017.10.010. Epub 2017 Oct 18. J Proteomics. 2018. PMID: 29055723 Free article. Review.
For each disease, a brief overview of the up to date knowledge about its pathogenesis is provided, followed by an insight into the most recent achievements on the proteome and metabolome of tissues and biological fluids, such as blood serum and urine, highlighting potentia …
For each disease, a brief overview of the up to date knowledge about its pathogenesis is provided, followed by an insight into the most rece …
Cyclovirus Vietnam DNA in immunodeficient patients.
Macera L, Focosi D, Vatteroni ML, Manzin A, Antonelli G, Pistello M, Maggi F. Macera L, et al. J Clin Virol. 2016 Aug;81:12-5. doi: 10.1016/j.jcv.2016.05.011. Epub 2016 May 20. J Clin Virol. 2016. PMID: 27270127
Positive patients showed low levels of CyCV-VN viremia. The virus was not detected in serum samples from healthy individuals. Longitudinal analysis of serum samples obtained from selected patients showed a stable or transient presence of circulating CyCV-VN. ...
Positive patients showed low levels of CyCV-VN viremia. The virus was not detected in serum samples from healthy individuals. Longitu …
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?
Schiavetti I, Inglese M, Frau J, Signoriello E, Caleri F, Stromillo ML, Ferrò MT, Rilla MT, Gandoglia I, Gazzola P, Brichetto G, Pasquali L, Grimaldi L, Ulivelli M, Marinelli F, Cordera S, Clerico M, Conte A, Salvetti M, Battaglia MA, Franciotta D, Uccelli A, Sormani MP; CovaXiMS Study Group. Schiavetti I, et al. Eur J Neurol. 2023 Aug;30(8):2357-2364. doi: 10.1111/ene.15830. Epub 2023 May 28. Eur J Neurol. 2023. PMID: 37154406

Compared to untreated patients, there was a 50-fold decrease (95% confidence interval [CI] = 14.3-100.0, p < 0.001) in serum SARS-CoV-2 antibody levels in those on rituximab, a 20-fold decrease (95% CI = 8.3-50.0, p < 0.001) in those on ocrelizumab, and a 2.3-fold de

…

Compared to untreated patients, there was a 50-fold decrease (95% confidence interval [CI] = 14.3-100.0, p < 0.001) in serum SARS-

…
Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy.
Focosi D, Maggi F, Mazzetti P, Pistello M. Focosi D, et al. Rev Med Virol. 2021 Mar;31(2):e2170. doi: 10.1002/rmv.2170. Epub 2020 Sep 21. Rev Med Virol. 2021. PMID: 33350017 Free PMC article. Review.
We review here the available methods by dissecting variations for each fundamental component of the VNT (i.e., virus type and dose, replication-competent cell line, serum, and detection system)....
We review here the available methods by dissecting variations for each fundamental component of the VNT (i.e., virus type and dose, replicat …
The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases.
Ceciliani F, Pocacqua V. Ceciliani F, et al. Curr Protein Pept Sci. 2007 Feb;8(1):91-108. doi: 10.2174/138920307779941497. Curr Protein Pept Sci. 2007. PMID: 17305563 Review.
Glycosylation is one of the most important post-translational modifications of proteins, and has been widely acknowledged as one of the most important ways to modulate both protein function and lifespan. The acute phase proteins are a major group of serum proteins whose co …
Glycosylation is one of the most important post-translational modifications of proteins, and has been widely acknowledged as one of the most …
Antibody Responses to SARS-CoV-2 Antigens in Humans and Animals.
Kim H, Seiler P, Jones JC, Ridout G, Camp KP, Fabrizio TP, Jeevan T, Miller LA, Throm RE, Ferrara F, Fredrickson RL, Lowe JF, Wang L, Odemuyiwa SO, Wan XF, Webby RJ. Kim H, et al. Vaccines (Basel). 2020 Nov 16;8(4):684. doi: 10.3390/vaccines8040684. Vaccines (Basel). 2020. PMID: 33207583 Free PMC article.
To optimize the public health response to coronavirus disease 2019 (COVID-19), we must first understand the antibody response to individual proteins on the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) and the antibody's cross reactivity to other coronaviru …
To optimize the public health response to coronavirus disease 2019 (COVID-19), we must first understand the antibody response to individual …
94 results